Dr. Arif Gulzar has obtained doctorate degree in Material Science and Engineering. His research focuses on cyclotron operation for the production of novel radioisotopes such as 68Ga etc and chelator free radiolabelling of nanoparticles for cancer theragnostic.
Long-term NIF user and collaborator, AdvanCell has secured $112m in Series C funding supported by Sanofi Ventures to advance its targeted alpha therapy for metastatic prostate cancer.
03 February 2025
New FDA-approved software, Chondral Quant, developed through a collaboration between The University of Queensland, Siemens Healthineers, and CSIRO, and supported by NIF’s ultra-high field MRI im
09 December 2024
There is currently no definitive way to track and predict the progression of motor neurone disease (MND). Dr Thomas Shaw from UQ School of Electrical Engineering and Computer Science is exploring inno
15 November 2024
“You walk in, and in less than a second, your total body is imaged…
05 September 2024
Melyssa L. Grieve, Patrick R. W. J. Davey, Paul V. Bernhardt, Craig M. Forsyth and Brett M. Paterson
Read Publication
Philip E. Mosley, Johan N. van der Meer, Lachlan H. W. Hamilton, Jurgen Fripp, Stephen Parker, Jayson Jeganathan, Michael Breakspear, Richard Parker, Rebecca Holland, Brittany L. Mitchell, Enda Byrne, Ian B. Hickie, Sarah E. Medland, Nicholas G. Martin & Luca Cocchi
Read Publication
James Humphries, Nicholas L. Fletcher, Stefan E. Sonderegger, Craig A. Bell, Kristian Kempe and Kristofer J. Thurecht
Read Publication
James L. Wood, Saikat Ghosh, Zachary H. Houston, Nicholas L. Fletcher, James Humphries, Karine Mardon, Dewan T. Akhter, William Tieu, Alesia Ivashkevich, Michael P. Wheatcroft, Kristofer J. Thurecht and Rachel Codd
Read Publication